Rubius Therapeutics, Inc. (RUBY)

NASDAQ: RUBY · IEX Real-Time Price · USD
0.280
+0.002 (0.68%)
Jan 27, 2023, 4:00 PM EST - Market closed

Stock Price Forecast

According to 7 stock analysts, the average 12-month stock price forecast for RUBY stock is $1.02, which predicts an increase of 264.29%. The lowest target is $1.01 and the highest is $1.05. On average, analysts rate RUBY stock as a sell.
Analyst Consensus: Sell
Target Low Average Median High
Price $1.01 $1.02 $1.02 $1.05
Change +260.71% +264.29% +264.29% +275.00%

Analyst Ratings

The average analyst rating for RUBY stock from 7 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating Aug '22Sep '22Oct '22Nov '22Dec '22Jan '23
Strong Buy 443300
Buy 444300
Hold 445444
Sell 000011
Strong Sell 000022
Total 1212121077

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.86
from -2.23
EPS Next Year
-0.66
from -1.86
Year 2017201820192020202120222023
Revenue
-------
Revenue Growth
-------
EPS
-5.55-2.27-2.08-2.08-2.23-1.86-0.66
EPS Growth
-------
No. Analysts -----44

Revenue Forecast

Revenue 20222023
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20222023
High - -
Avg - -
Low - -

EPS Forecast

EPS 20222023
High -1.89 -0.34
Avg -1.86 -0.66
Low -1.81 -0.96

EPS Growth

EPS Growth 20222023
High - -
Avg - -
Low - -
Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.